Page values for "Canertinib dihydrochloride"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 860,923 |
| _pageName | Page | Canertinib dihydrochloride |
| _pageTitle | String | Canertinib dihydrochloride |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Canertinib dihydrochloride |
| Short_definition | String | Canertinib dihydrochloride - (pronounced) (can-ER-tih-nib dy-HY-droh-KLOR-ide) substance being studied to treat some types of cancer. Canertinib dihydrochloride blocks the action of proteins called epidermal growth factor receptors and can cause cancer cells to die. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |